Company:  IDERA PHARMACEUTICALS, IN ... (IDRA)
Form Type:  8-K
Filing Date:  6/6/2019 
CIK:  0000861838 
Address:  505 EAGLEVIEW BOULEVARD
SUITE 212
 
City, State, Zip:  EXTON, Pennsylvania 19341 
Telephone:  (484) 348-1600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.06  
Change: 
-0.05 (-2.37%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$59.48M
Trade IDRA now with

© 2019  
Description of Business
We are a clinical-stage biopharmaceutical company with a business strategy focused on the clinical development, and ultimately the commercialization, of drug candidates for both oncology and rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. Our current focus is on our Toll-like receptor, or TLR, agonist, tilsotolimod (IMO-2125), for oncology. We believe we can develop and commercialize targeted therapies on our own. To the extent we seek to develop drug candidates for broader disease indications, we have entered into and may explore additional collaborative alliances to support development and commercialization. TLRs are key receptors of the immune system and play a role in innate and adaptive immunity. As a result, we believe TLRs are potential therapeutic targets for the treatment of a broad range of diseases.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02 Departure of Directors or ...
      Item 5.07. Submission of Matters to a ...
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and ...
    SIGNATURES